VeriMomaesculus hippocastanum fruit powder est-il sûr pendant la grossesse ?
No EU Annex II (ban) or Annex III (restriction) listing or harmonised CLP reproductive classification was identified for Aesculus hippocastanum (CAS 8053‑39‑2). Authoritative reviews (EMA assessment, NCCIH) state safety in pregnancy/lactation is not established and recommend avoidance for lack of data rather than reporting proven reproductive toxicity; peer‑reviewed reviews of topical cosmetic uses report limited adverse effects (contact dermatitis) but not developmental/reproductive hazards. Thus there is no direct evidence of reproductive hazard, but exposure from topical use is considered low but measurable. ([ema.europa.eu](https://www.ema.europa.eu/documents/herbal-report/final-assessment-report-aesculus-hippocastanum-l-cortex_en.pdf?utm_source=openai))
Related ingredients
Frequently asked questions
- aesculus hippocastanum fruit powder est-il sûr pendant la grossesse ?
- No EU Annex II (ban) or Annex III (restriction) listing or harmonised CLP reproductive classification was identified for Aesculus hippocastanum (CAS 8053‑39‑2). Authoritative reviews (EMA assessment, NCCIH) state safety in pregnancy/lactation is not established and recommend avoidance for lack of data rather than reporting proven reproductive toxicity; peer‑reviewed reviews of topical cosmetic uses report limited adverse effects (contact dermatitis) but not developmental/reproductive hazards. Thus there is no direct evidence of reproductive hazard, but exposure from topical use is considered low but measurable. ([ema.europa.eu](https://www.ema.europa.eu/documents/herbal-report/final-assessment-report-aesculus-hippocastanum-l-cortex_en.pdf?utm_source=openai))
- aesculus hippocastanum fruit powder est-il sûr pendant l'allaitement ?
- Same rationale as pregnancy: no harmonised reproductive/CMR classification or EU ban/restriction found; EMA/NCCIH note insufficient data and advise caution. Maternal topical exposure could lead to low but measurable systemic exposure; no infant‑specific toxicity data were found. ([ema.europa.eu](https://www.ema.europa.eu/documents/herbal-report/final-assessment-report-aesculus-hippocastanum-l-cortex_en.pdf?utm_source=openai))
- aesculus hippocastanum fruit powder est-il sûr pour la peau de bébé ?
- No evidence of intrinsic reproductive or developmental toxicity to infants from topical exposure to cosmetic‑grade horse‑chestnut extract. Because baby skin (0–3 yr) has higher permeability and surface‑area‑to‑weight, exposure score is increased by +1 relative to adults (topical adult e=1 → baby e=2). Reports flag contact dermatitis cases but not systemic developmental effects. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/18503457/?utm_source=openai))
- Comment VeriMom évalue-t-il aesculus hippocastanum fruit powder ?
- VeriMom évalue aesculus hippocastanum fruit powder à 93/100 (pas de risques connus) sur la base du statut EU CosIng, des classifications ECHA et des études PubMed.
- Quelles sont les alternatives sûres à aesculus hippocastanum fruit powder pendant la grossesse ?
- Consultez notre liste d'alternatives sûres à aesculus hippocastanum fruit powder basée sur une fonction similaire et une classification sans risques connus.
Vérifiez chaque étiquette en 2 secondes
Obtenez VeriMom gratuitement — scannez n'importe quel produit et voyez le score de sécurité grossesse instantanément.
Avis Médical
Ces informations sont fournies à titre éducatif uniquement et ne constituent pas un avis médical. Les scores de sécurité sont basés sur des données accessibles au public et peuvent ne pas refléter tous les risques. Consultez toujours votre professionnel de santé avant d'utiliser tout produit pendant la grossesse ou l'allaitement.